Biosign announces resignation of CEO



    TORONTO, June 20 /CNW/ - Biosign Technologies Inc. (CNQ: BIOS) today
announced the resignation of Chairman and CEO Richard Potts effective
immediately.
    "While pleased with much of the progress that has been made by Biosign,
it is with deep regret but with great hope for the future of Biosign that I
provide my resignation to the board of directors," said Richard Potts. "I
intend to assist Dr. Leca in every possible manner in moving Biosign toward
its important goal of becoming the world's health monitor."
    In the interim Dr. Leca will assume these roles.

    About Biosign

    Biosign develops technologies, products and initiatives to address
critical problems in global health care. The company is committed to becoming
the "world's health monitor" with a robust, integrated and portable system
that provides valuable information for all parties concerned - patients,
physicians, pharmacists, payors and pharmaceutical companies - and a wide
range of potential revenue-generating services. Biosign's breakthrough
technology and continued innovation serve the company's mission to make health
care safe, simple, and sensible.

    %SEDAR: 00014068E




For further information:

For further information: Biosign, Radu Leca, President & CTO, Phone:
(416) 218-9800 ext. 222, Email: radul@biosign.com

Organization Profile

Biosign Technologies Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890